Healthcare InvestmentAI-Designed Antibody BD200 Outperforms Existing Cancer Drugs as $60M SPAC Targets AI BiotechSalvado•Apr 19, 2026
Biotech InvestmentAI-Designed Antibody BD200 Enters Clinical Trials as Biotech Sector Targets 2026-2027 Regulatory WaveSalvado•Apr 18, 2026
Healthcare & Pharma InvestmentFDA Priority Reviews and Cell Therapy Acquisitions Signal Biotech Sector AccelerationSalvado•Apr 16, 2026
Biotech InvestmentsKelun-Biotech Advances 30+ Oncology Candidates as ADC Competition Intensifies Through 2029Salvado•Mar 26, 2026
Healthcare InvestmentPrecision Oncology Sector Reaches Inflection Point as Seven Companies Advance Toward FDA SubmissionsViaNews Editorial Team (Finance)•Feb 15, 2026
